Piroxicam
"Piroxicam" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A cyclooxygenase inhibiting, non-steroidal anti-inflammatory agent (NSAID) that is well established in treating rheumatoid arthritis and osteoarthritis and used for musculoskeletal disorders, dysmenorrhea, and postoperative pain. Its long half-life enables it to be administered once daily.
| Descriptor ID |
D010894
|
| MeSH Number(s) |
D02.886.665.500 D03.383.855.500
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Piroxicam".
Below are MeSH descriptors whose meaning is more specific than "Piroxicam".
This graph shows the total number of publications written about "Piroxicam" by people in this website by year, and whether "Piroxicam" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Piroxicam" by people in Profiles.
-
Amura CR, Fontan PA, Sanjuan N, Nociari MM, Buzzola FR, Sordelli DO. Tumor necrosis factor alpha plus interleukin 1 beta treatment protects granulocytopenic mice from Pseudomonas aeruginosa lung infection: role of an unusual inflammatory response. APMIS. 1995 Jun; 103(6):447-59.
-
Font?n PA, Amura CR, Buzzola FR, Sordelli DO. Modulation of human polymorphonuclear leukocyte chemotaxis and superoxide anion production by Pseudomonas aeruginosa exoproducts, IL-1 beta and piroxicam. FEMS Immunol Med Microbiol. 1995 Jan; 10(2):139-44.
-
Font?n PA, Amura CR, Sordelli DO. The effect of a cyclooxygenase inhibitor on the in vivo polymorphonuclear leukocyte migration to Pseudomonas aeruginosa peptide chemotactins. Agents Actions. 1993 Sep; 40(1-2):106-9.
-
Sordelli DO, Font?n PA, Amura CR. Piroxicam-copper complexes: inhibition of polymorphonuclear leukocyte migration to Pseudomonas aeruginosa chemotactins in vivo and superoxide dismutase-like activity in vitro. Agents Actions. 1993 Mar; 38(3-4):196-201.
-
Font?n PA, Amura CR, Sordelli DO. Treatment with a non-steroidal anti-inflammatory agent delays the growth of spontaneous pulmonary metastases of a mammary adenocarcinoma of non-detected immunogenicity. Br J Cancer. 1992 Nov; 66(5):800-4.